Pain Drug Developer Adynxx Picks Up $16M for Another Clinical Trial

From Xconomy VC, Deals, & Startups
January 10, 2017 - 5:58pm

Despite the wide range of pain relievers available, many patients find these drugs fall short of easing pain after surgery and during rehabilitation. Drug developer Adynxx is trying to address that pain with a new treatment developed to be administered to patients during surgery. The San Francisco-based biotech now has $16 million to continue testing […]



Continue reading this article »